You are here

Home

Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is C  [Clear All Filters]
2022
Frangou S, Modabbernia A, Williams SCR, Papachristou E, Doucet GE, Agartz I, Aghajani M, Akudjedu TN, Albajes-Eizagirre A, Alnaes D et al..  2022.  Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3-90 years.. Hum Brain Mapp. 43(1):431-451.
2021
Andrews SJ, Fulton-Howard B, O'Reilly P, Marcora E, Goate AM.  2021.  Causal Associations Between Modifiable Risk Factors and the Alzheimer's Phenome.. Ann Neurol. 89(1):54-65.
Patel D, Zhang X, Farrell JJ, Chung J, Stein TD, Lunetta KL, Farrer LA.  2021.  Cell-type-specific expression quantitative trait loci associated with Alzheimer disease in blood and brain tissue.. Transl Psychiatry. 11(1):250.
de Erausquin GA, Snyder H, Carrillo M, Hosseini AA, Brugha TS, Seshadri S.  2021.  The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning.. Alzheimers Dement. 17(6):1056-1065.
de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen IE, Pedersen NL, Stringa N, Zettergren A, Hernández I et al..  2021.  Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.. Nat Commun. 12(1):3417.
Patrick E, Olah M, Taga M, Klein H-U, Xu J, White CC, Felsky D, Agrawal S, Gaiteri C, Chibnik LB et al..  2021.  A cortical immune network map identifies distinct microglial transcriptional programs associated with β-amyloid and Tau pathologies.. Transl Psychiatry. 11(1):50.
2020
Peloso GM, Beiser AS, Satizabal CL, Xanthakis V, Vasan RS, Pase MP, DeStefano AL, Seshadri S.  2020.  Cardiovascular health, genetic risk, and risk of dementia in the Framingham Heart Study.. Neurology. 95(10):e1341-e1350.
McGrath ER, Himali JJ, Xanthakis V, Duncan MS, Schaffer JE, Ory DS, Peterson LR, DeCarli C, Pase MP, Satizabal CL et al..  2020.  Circulating ceramide ratios and risk of vascular brain aging and dementia.. Ann Clin Transl Neurol.
Kling MA, Goodenowe DB, Senanayake V, MahmoudianDehkordi S, Arnold M, Massaro TJ, Baillie R, Han X, Leung Y-Y, Saykin AJ et al..  2020.  Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau.. Alzheimers Dement. 16(9):1234-1247.
Wang L, Qiao Y, Zhang H, Zhang Y, Hua J, Jin S, Liu G.  2020.  Circulating Vitamin D Levels and Alzheimer's Disease: A Mendelian Randomization Study in the IGAP and UK Biobank.. J Alzheimers Dis. 73(2):609-618.
Peng B, Yao X, Risacher SL, Saykin AJ, Shen L, Ning X.  2020.  Cognitive biomarker prioritization in Alzheimer's Disease using brain morphometric data.. BMC Med Inform Decis Mak. 20(1):319.
Armstrong NJ, Mather KA, Sargurupremraj M, Knol MJ, Malik R, Satizabal CL, Yanek LR, Wen W, Gudnason VG, Dueker ND et al..  2020.  Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities.. Stroke. 51(7):2111-2121.
Srinivasan D, Erus G, Doshi J, Wolk DA, Shou H, Habes M, Davatzikos C.  2020.  A comparison of Freesurfer and multi-atlas MUSE for brain anatomy segmentation: Findings about size and age bias, and inter-scanner stability in multi-site aging studies.. Neuroimage. 223:117248.
Breuza L, Arighi CN, Argoud-Puy G, Casals-Casas C, Estreicher A, Famiglietti MLivia, Georghiou G, Gos A, Gruaz-Gumowski N, Hinz U et al..  2020.  A Coordinated Approach by Public Domain Bioinformatics Resources to Aid the Fight Against Alzheimer's Disease Through Expert Curation of Key Protein Targets.. J Alzheimers Dis. 77(1):257-273.
Keys KL, C Y Mak A, White MJ, Eckalbar WL, Dahl AW, Mefford J, Mikhaylova AV, Contreras MG, Elhawary JR, Eng C et al..  2020.  On the cross-population generalizability of gene expression prediction models.. PLoS Genet. 16(8):e1008927.
Ouellette AR, Neuner SM, Dumitrescu L, Anderson LC, Gatti DM, Mahoney ER, Bubier JA, Churchill G, Peters L, Huentelman MJ et al..  2020.  Cross-Species Analyses Identify Dlgap2 as a Regulator of Age-Related Cognitive Decline and Alzheimer's Dementia.. Cell Rep. 32(9):108091.
2019
Cali CP, Patino M, Tai YKit, Ho WYun, McLean CA, Morris CM, Seeley WW, Miller BL, Gaig C, Vonsattel JPaul G et al..  2019.  C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy.. Acta Neuropathol. 138(5):795-811.
McGrath ER, Himali JJ, Levy D, Conner SC, Pase MP, Abraham CR, Courchesne P, Satizabal CL, Vasan RS, Beiser AS et al..  2019.  Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study.. PLoS One. 14(3):e0213321.
Georgakis MK, Malik R, Björkbacka H, Pana TAlexandru, Demissie S, Ayers C, Elhadad MA, Fornage M, Beiser AS, Benjamin EJ et al..  2019.  Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: Meta-Analysis of Population-Based Studies Involving 17 180 Individuals.. Circ Res. 125(8):773-782.
Ullah E, Mall R, Abbas MM, Kunji K, Nato AQ, Bensmail H, Wijsman EM, Saad M.  2019.  Comparison and assessment of family- and population-based genotype imputation methods in large pedigrees.. Genome Res. 29(1):125-134.
Ma Y, Jun GR, Chung J, Zhang X, Kunkle BW, Naj AC, White CC, Bennett DA, De Jager PL, Mayeux R et al..  2019.  CpG-related SNPs in the MS4A region have a dose-dependent effect on risk of late-onset Alzheimer disease.. Aging Cell. 18(4):e12964.
2018
Raman MR, Himali JJ, Conner SC, DeCarli C, Vasan RS, Beiser AS, Seshadri S, Maillard P, Satizabal CL.  2018.  Circulating Vascular Growth Factors and Magnetic Resonance Imaging Markers of Small Vessel Disease and Atrophy in Middle-Aged Adults.. Stroke. 49(9):2227-2229.

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer